Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) EBIT (2016 - 2025)

INVO Fertility has reported EBIT over the past 15 years, most recently at -$1.6 million for Q3 2025.

  • Quarterly EBIT fell 25.77% to -$1.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$19.0 million through Sep 2025, down 207.65% year-over-year, with the annual reading at -$1.9 million for FY2024, 71.77% up from the prior year.
  • EBIT was -$1.6 million for Q3 2025 at INVO Fertility, up from -$3.0 million in the prior quarter.
  • Over five years, EBIT peaked at $5.7 million in Q4 2022 and troughed at -$17.1 million in Q1 2025.
  • The 5-year median for EBIT is -$1.9 million (2024), against an average of -$1.8 million.
  • Year-over-year, EBIT surged 343.67% in 2021 and then tumbled 1034.42% in 2025.
  • A 5-year view of EBIT shows it stood at $4.4 million in 2021, then surged by 30.97% to $5.7 million in 2022, then tumbled by 126.44% to -$1.5 million in 2023, then soared by 282.39% to $2.8 million in 2024, then crashed by 159.45% to -$1.6 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's EBIT are -$1.6 million (Q3 2025), -$3.0 million (Q2 2025), and -$17.1 million (Q1 2025).